comparemela.com

Latest Breaking News On - Xenon pharmaceuticals company profile - Page 1 : comparemela.com

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)

Stock Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada
Wellington
New-zealand-general
New-zealand
Steven-gannon
Sherrington-robin
Capital-international-investors
News-ratings-for-xenon-pharmaceuticals-daily
Wellington-management-group
Citigroup
Royal-bank
Avoro-capital-advisors

Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down Following Analyst Downgrade

Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down Following Analyst Downgrade
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada
China
Steven-gannon
Sherrington-robin
Needham-company
Financial-services-group-inc
China-universal-asset-management-co
Capital-partners
Nasdaq
Institutional-investors-weigh-in-on-xenon-pharmaceuticals
Royal-bank
Tower-research-capital

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Canada
Sherrington-robin
Steven-gannon
Analyst-recommendations-for-xenon-pharmaceuticals
Xenon-pharmaceuticals
Securities-exchange-commission
Xenon-pharmaceuticals-inc
Citigroup
Xenon-pharmaceuticals-company-profile
Lord-abbett
Cantor-fitzgerald
Royal-bank

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives $59.44 Average PT from Analysts

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Free Report) has earned an average recommendation of “Buy” from the nine analysts that are currently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have issued ratings on the stock in […]

United-states
Canada
Wellington
New-zealand-general
New-zealand
America
Sherrington-robin
Steven-gannon
Needham-company
Xenon-pharmaceuticals
Xenon-pharmaceuticals-stock
Timessquare-capital-management

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of "Buy" from Analysts

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of "Buy" from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Wellington
New-zealand-general
New-zealand
America
Sherrington-robin
Robertw-baird
Steven-gannon
Wellington-management-group
Nasdaq
News-ratings-for-xenon-pharmaceuticals-daily

vimarsana © 2020. All Rights Reserved.